Young adults had been widely perceived as a low-risk group for COVID-19 severity; therefore, they were deprioritised within the mass vaccination strategies as their prognosis of COVID-19 infection is relatively more favourable than older age groups. On the other hand, vaccination of this demographic group is indispensable to achieve herd immunity. A cross-sectional survey-based study was used to evaluate the side effects of mRNA-based COVID-19 vaccines among university students in the Czech Republic. The validated questionnaire was delivered in a digital form, and it consisted of demographic data; COVID-19 vaccine-related anamnesis; and local, systemic, orofacial, and skin-related side effects' prevalence, onset, and duration. Out of the 539 included participants, 70.1% were females and 45.8% were <23 years old. The vast majority (95.2%) reported at least one side effect. The most common side effect was injection site pain (91.8%), followed by fatigue (62.5%), headache (36.4%), and muscle pain (34.9%). The majority of local side effects occurred after both doses (74.4%), while most systemic side effects occurred after the second dose only (56.2%). Most local (94.2%) and systemic (93.3%) side effects resolved within three days after vaccination. Females participants' adjusted odds ratio (AOR) showed they were 2.566 (CI 95%: 1.103-5.970) times more likely to experience post-vaccination side effects, and the participants who received two doses reported an increased AOR of 1.896 (0.708-5.077) for experiencing side effects. The results of this study imply that mRNA-based COVID-19 vaccines are highly probably safe for young adults, and further studies are required to investigate the role of medical anamnesis, prior COVID-19 infection, and gender in side effects incidence.

Czech National Centre for Evidence Based Healthcare and Knowledge Translation Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Nursing and Midwifery Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Public Health Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Zobrazit více v PubMed

Mercier G., Arquizan C., Roubille F. Understanding the effects of COVID-19 on health care and systems. Lancet Public Health. 2020;5:e524. doi: 10.1016/S2468-2667(20)30213-9. PubMed DOI PMC

Chang A.Y., Cullen M.R., Harrington R.A., Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: A review. J. Intern. Med. 2021;289:450–462. doi: 10.1111/joim.13184. PubMed DOI PMC

Richards M., Anderson M., Carter P., Ebert B.L., Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 2020;1:565–567. doi: 10.1038/s43018-020-0074-y. PubMed DOI PMC

Bojdani E., Rajagopalan A., Chen A., Gearin P., Olcott W., Shankar V., Cloutier A., Solomon H., Naqvi N.Z., Batty N., et al. COVID-19 Pandemic: Impact on psychiatric care in the United States. Psychiatry Res. 2020;289:113069. doi: 10.1016/j.psychres.2020.113069. PubMed DOI PMC

Di Gennaro F., Gualano G., Timelli L., Vittozzi P., Di Bari V., Libertone R., Cerva C., Pinnarelli L., Nisii C., Ianniello S., et al. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics. 2021;10:272. doi: 10.3390/antibiotics10030272. PubMed DOI PMC

Riad A., Boccuzzi M., Pold A., Krsek M. The alarming burden of non-communicable diseases in COVID-19 new normal: Implications on oral health. Oral Dis. 2020;27:791–792. doi: 10.1111/odi.13491. PubMed DOI PMC

Pan American Health Organization (PAHO) of the World Health Organization (WHO) Introducing COVID-19 Vaccination: Guidance for Determining Priority Groups and Microplanning. [(accessed on 13 October 2021)];2021 January 18; Version 1. Available online: https://iris.paho.org/handle/10665.2/53318.

Frederiksen L.S.F., Zhang Y., Foged C., Thakur A. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. Front. Immunol. 2020;11:1817. doi: 10.3389/fimmu.2020.01817. PubMed DOI PMC

MacDonald N.E., Eskola J., Liang X., Chaudhuri M., Dube E., Gellin B., Goldstein S., Larson H., Manzo M.L., Reingold A., et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036. PubMed DOI

Strategic Advisory Group of Experts on Immunization (SAGE) Vaccine Hesitancy Survey Questions Related to SAGE Vaccine Hesitancy Matrix. WHO; Geneva, Switzerland:

Van Khuc Q., Nguyen T., Nguyen T., Pham L., Le D.-T., Ho H.-H., Truong T.-B., Tran Q.-K. Young Adults’ Intentions and Rationales for COVID-19 Vaccination Participation: Evidence from a Student Survey in Ho Chi Minh City, Vietnam. Vaccines. 2021;9:794. doi: 10.3390/vaccines9070794. PubMed DOI PMC

Lucia V.C., Kelekar A., Afonso N.M. COVID-19 vaccine hesitancy among medical students. J. Public Health. 2020;43:445–449. doi: 10.1093/pubmed/fdaa230. PubMed DOI PMC

Tam C.C., Qiao S., Li X. Factors associated with decision making on COVID-19 vaccine acceptance among college students in South Carolina. medRxiv. 2020:1–12. doi: 10.1101/2020.12.03.20243543. PubMed DOI PMC

Saied S.M., Saied E.M., Kabbash I.A., Abdo S.A.E. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021;93:4280–4291. doi: 10.1002/jmv.26910. PubMed DOI PMC

Soares P., Rocha J.V., Moniz M., Gama A., Laires P.A., Pedro A.R., Dias S., Leite A., Nunes C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines. 2021;9:300. doi: 10.3390/vaccines9030300. PubMed DOI PMC

Yoda T., Katsuyama H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines. 2021;9:48. doi: 10.3390/vaccines9010048. PubMed DOI PMC

Wang J., Jing R., Lai X., Zhang H., Lyu Y., Knoll M.D., Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8:482. doi: 10.3390/vaccines8030482. PubMed DOI PMC

Riad A., Abdulqader H., Morgado M., Domnori S., Koščík M., Mendes J.J., Klugar M., Kateeb E. Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy. Vaccines. 2021;9:566. doi: 10.3390/vaccines9060566. PubMed DOI PMC

Liao J., Fan S., Chen J., Wu J., Xu S., Guo Y., Li C., Zhang X., Wu C., Mou H., et al. Epidemiological and Clinical Characteristics of COVID-19 in Adolescents and Young Adults. Innovation. 2020;1:100001. doi: 10.1016/J.XINN.2020.04.001. PubMed DOI PMC

Elmer T., Mepham K., Stadtfeld C. Students under lockdown: Comparisons of students’ social networks and mental health before and during the COVID-19 crisis in Switzerland. PLoS ONE. 2020;15:e0236337. doi: 10.1371/journal.pone.0236337. PubMed DOI PMC

Fawaz M., Samaha A. E-learning: Depression, anxiety, and stress symptomatology among Lebanese university students during COVID-19 quarantine. Nurs. Forum. 2021;56:52–57. doi: 10.1111/nuf.12521. PubMed DOI

Alawia R., Riad A., Kateeb E. Risk perception and readiness of dental students to treat patients amid COVID-19: Implication for dental education. Oral Dis. 2020 doi: 10.1111/odi.13593. PubMed DOI PMC

Marotta C., Nacareia U., Estevez A., Tognon F., Genna G., De Meneghi G., Occa E., Ramirez L., Lazzari M., Di Gennaro F., et al. Mozambican Adolescents and Youths during the COVID-19 Pandemic: Knowledge and Awareness Gaps in the Provinces of Sofala and Tete. Healthcare. 2021;9:321. doi: 10.3390/healthcare9030321. PubMed DOI PMC

Alawia R., Riad A., Kateeb E. Knowledge and attitudes among dental students about COVID-19 and its precautionary measures: A cross-sectional study. J. Oral Med. Oral Surg. 2021;27:17. doi: 10.1051/mbcb/2020056. DOI

Riad A., Pokorná A., Antalová N., Krobot M., Zviadadze N., Serdiuk I., Koščík M., Klugar M. Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study. Vaccines. 2021;9:948. doi: 10.3390/vaccines9090948. PubMed DOI PMC

Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., Sævik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;2021:1–7. doi: 10.1038/s41591-021-01433-3. PubMed DOI PMC

Klugar M., Riad A. COVID-19 Vaccines Safety Tracking (CoVaST) [(accessed on 15 July 2021)]; Available online: https://clinicaltrials.gov/ct2/show/NCT04834869.

Riad A., Schünemann H., Attia S., Peričić T.P., Žuljević M.F., Jürisson M., Kalda R., Lang K., Morankar S., Yesuf E.A., et al. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects. Int. J. Environ. Res. Public Health. 2021;18:7859. doi: 10.3390/ijerph18157859. PubMed DOI PMC

Masaryk University Clubs & Associations at the Faculty of Medicine. [(accessed on 20 June 2021)]. Available online: https://www.muni.cz/en/students/student-clubs-associations/contact-1/faculty-of-medicine.

Ministerstvo Vnitra Časová osa Očkování. [(accessed on 21 July 2021)]; Available online: https://covid.gov.cz/situace/registrace-na-ockovani/casova-osa-ockovani.

Centers for Disease Control and Prevention, (CDC) Epi InfoTM for Windows. [(accessed on 25 December 2020)]; Available online: https://www.cdc.gov/epiinfo/pc.html.

Czech Statistical Office Statistical Yearbook of the Czech Republic. 2020. [(accessed on 1 July 2021)]. Available online: https://www.czso.cz/csu/czso/statistical-yearbook-of-the-czech-republic-2020.

Riad A., Pokorná A., Attia S., Klugarová J., Koščík M., Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J. Clin. Med. 2021;10:1428. doi: 10.3390/jcm10071428. PubMed DOI PMC

Riad A., Pokorná A., Mekhemar M., Conrad J., Klugarová J., Koščík M., Klugar M., Attia S. Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States. Vaccines. 2021;9:673. doi: 10.3390/vaccines9060673. PubMed DOI PMC

Klugar M., Riad A., Mekhemar M., Conrad J., Buchbender M., Howaldt H.-P., Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology. 2021;10:752. doi: 10.3390/biology10080752. PubMed DOI PMC

Riad A., Sağıroğlu D., Üstün B., Pokorná A., Klugarová J., Attia S., Klugar M. Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey. J. Clin. Med. 2021;10:2629. doi: 10.3390/jcm10122629. PubMed DOI PMC

Riad A., Hocková B., Kantorová L., Slávik R., Spurná L., Stebel A., Havriľak M., Klugar M. Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals. 2021;14:873. doi: 10.3390/ph14090873. PubMed DOI PMC

Pourhoseingholi M.A., Vahedi M., Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol. Hepatol. From Bed Bench. 2013;6:14. PubMed PMC

Centers for Disease Control and Prevention (CDC) Population Survey or Descriptive Study. [(accessed on 19 May 2021)]; Available online: https://www.cdc.gov/epiinfo/user-guide/statcalc/samplesize.html.

World Medical Association World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA J. Am. Med. Assoc. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053. PubMed DOI

Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. UroToday Int. J. 2009;2 doi: 10.1097/EDE.0b013e3181577654. PubMed DOI

Proton Technologies AG General Data Protection Regulation (GDPR) Compliance Guidelines. [(accessed on 1 May 2020)]. Available online: https://gdpr.eu/

SPSS Inc. IBM SPSS Statistics 27. [(accessed on 14 March 2021)]. Available online: https://www.ibm.com/support/pages/node/3006603.

Kadali R.A.K., Janagama R., Peruru S., Gajula V., Madathala R.R., Chennaiahgari N., Malayala S. V Adverse effects of COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J. Med. Virol. 2021:1–10. doi: 10.1002/jmv.26996. PubMed DOI PMC

Mathioudakis A.G., Ghrew M., Ustianowski A., Ahmad S., Borrow R., Papavasileiou L.P., Petrakis D., Bakerly N.D. Self-reported real-world safety and reactogenicity of covid-19 vaccines: A vaccine recipient survey. Life. 2021;11:249. doi: 10.3390/life11030249. PubMed DOI PMC

El-Shitany N.A., Harakeh S., Badr-Eldin S.M., Bagher A.M., Eid B.G., Almukadi H.S., Alghamdi B.S., Alahmadi A.A., Hassan N.A., Sindi N., et al. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study. Int. J. Gen. Med. 2021;14:1389–1401. doi: 10.2147/IJGM.S310497. PubMed DOI PMC

Abu-Hammad O., Alduraidi H., Abu-Hammad S., Alnazzawi A., Babkair H., Abu-Hammad A., Nourwali I., Qasem F., Dar-Odeh N. Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines. Vaccines. 2021;9:577. doi: 10.3390/vaccines9060577. PubMed DOI PMC

Alhazmi A., Alamer E., Daws D., Hakami M., Darraj M., Abdelwahab S., Maghfuri A., Algaissi A. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 2021;9:674. doi: 10.3390/vaccines9060674. PubMed DOI PMC

Menni C., Klaser K., May A., Polidori L., Capdevila J., Louca P., Sudre C.H., Nguyen L.H., Drew D.A., Merino J., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet. Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00224-3. PubMed DOI PMC

Cuschieri S., Borg M., Agius S., Souness J., Brincat A., Grech V. Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta’s state hospital. Int. J. Clin. Pract. 2021:e14605. doi: 10.1111/IJCP.14605. PubMed DOI PMC

Centres for Diseases Control and Prevention (CDC) Reactions and Adverse Events of the Pfizer-BioNTech COVID-19 Vaccine. Centres for Diseases Control and Prevention (CDC); Atlanta, GA, USA: 2021.

Gee J. First Month of COVID-19 Vaccine Safety Monitoring—United States, December 14, 2020–January 13, 2021. MMWR. Morb. Mortal. Wkly. Rep. 2021;70:283–288. doi: 10.15585/mmwr.mm7008e3. PubMed DOI PMC

Di Resta C., Ferrari D., Viganò M., Moro M., Sabetta E., Minerva M., Ambrosio A., Locatelli M., Tomaiuolo R. The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects. Vaccines. 2021;9:522. doi: 10.3390/vaccines9050522. PubMed DOI PMC

Trigunaite A., Dimo J., Jørgensen T.N. Suppressive effects of androgens on the immune system. Cell. Immunol. 2015;294:87–94. doi: 10.1016/j.cellimm.2015.02.004. PubMed DOI

Khan D., Ansar Ahmed S. The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases. Front. Immunol. 2016;6:635. doi: 10.3389/fimmu.2015.00635. PubMed DOI PMC

Klein S.L., Jedlicka A., Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010;10:338–349. doi: 10.1016/S1473-3099(10)70049-9. PubMed DOI PMC

Bartley E.J., Fillingim R.B. Sex differences in pain: A brief review of clinical and experimental findings. BJA Br. J. Anaesth. 2013;111:52. doi: 10.1093/bja/aet127. PubMed DOI PMC

Himmelstein M.S., Sanchez D.T. Masculinity impediments: Internalized masculinity contributes to healthcare avoidance in men and women. J. Health Psychol. 2014;21:1283–1292. doi: 10.1177/1359105314551623. PubMed DOI

Klein S.L., Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J. Infect. Dis. 2014;209:S114. doi: 10.1093/infdis/jiu066. PubMed DOI PMC

Halsey N.A., Griffioen M., Dreskin S.C., Dekker C.L., Wood R., Sharma D., Jones J.F., LaRussa P.S., Garner J., Berger M., et al. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS. Vaccine. 2013;31:6107–6112. doi: 10.1016/j.vaccine.2013.09.066. PubMed DOI

Robert W., Frenck J., Klein N.P., Kitchin N., Gurtman A., Absalon J., Lockhart S., Perez J.L., Walter E.B., Senders S., et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N. Engl. J. Med. 2021;385:239–250. doi: 10.1056/NEJMOA2107456. PubMed DOI PMC

Azzi L., Toia M., Stevanello N., Maggi F., Forlani G. An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine. Oral Dis. 2021 doi: 10.1111/odi.13874. PubMed DOI PMC

Manfredi M., Ghidini G., Ridolo E., Pizzi S. Oral lesions postinjection of the first administration of Pfizer-BioNTech SARS-CoV-2 (BNT162b2) vaccine. Oral Dis. 2021 doi: 10.1111/odi.13912. PubMed DOI PMC

Riad A., Gad A., Hockova B., Klugar M. Oral candidiasis in non-severe COVID-19 patients: Call for antibiotic stewardship. Oral Surg. 2020 doi: 10.1111/ors.12561. PubMed DOI PMC

Riad A., Klugar M., Krsek M. COVID-19 Related Oral Manifestations, Early Disease Features? Oral Dis. 2020 doi: 10.1111/odi.13516. PubMed DOI PMC

Riad A., Kassem I., Issa J., Badrah M., Klugar M. Angular cheilitis of COVID-19 patients: A case-series and literature review. Oral Dis. 2020 doi: 10.1111/odi.13675. PubMed DOI PMC

Riad A., Kassem I., Badrah M., Klugar M. The manifestation of oral mucositis in COVID-19 patients: A case-series. Dermatol. Ther. 2020;33 doi: 10.1111/dth.14479. PubMed DOI PMC

Riad A., Kassem I., Hockova B., Badrah M., Klugar M. Tongue ulcers associated with SARS-CoV-2 infection: A case series. Oral Dis. 2020 doi: 10.1111/odi.13635. PubMed DOI

Riad A., Kassem I., Stanek J., Badrah M., Klugarova J., Klugar M. Aphthous Stomatitis in COVID-19 Patients: Case-series and Literature Review. Dermatol. Ther. 2021 doi: 10.1111/dth.14735. PubMed DOI PMC

Al-Khanati N.M., Riad A., Sahloul M.E., Klugar M. Aphthous-like stomatitis of COVID-19 patients. Braz. J. Oral Sci. 2020;19:e201354. doi: 10.20396/bjos.v19i0.8661354. DOI

Hocková B., Riad A., Valky J., Šulajová Z., Stebel A., Slávik R., Bečková Z., Pokorná A., Klugarová J., Klugar M. Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases. J. Clin. Med. 2021;10:581. doi: 10.3390/jcm10040581. PubMed DOI PMC

Riad A., Gomaa E., Hockova B., Klugar M. Oral Candidiasis of COVID-19 Patients: Case Report and Review of Evidence. J. Cosmet. Dermatol. 2021;20:1580–1584. doi: 10.1111/jocd.14066. PubMed DOI PMC

Gronbeck C., Grant-Kels J.M. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them! Clin. Dermatol. 2021 doi: 10.1016/j.clindermatol.2021.05.027. PubMed DOI PMC

COVID-19: Přehled Očkování|Onemocnění Aktuálně od MZČR. [(accessed on 22 July 2021)]. Available online: https://onemocneni-aktualne.mzcr.cz/vakcinace-cr.

Editorial: COVID-19 Vaccines Safety Tracking (CoVaST): Part I

Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers

Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees

COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study

COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study

The Impact of Information Sources on COVID-19-Related Knowledge, Attitudes, and Practices (KAP) among University Students: A Nationwide Cross-Sectional Study